Skip to main content

Advertisement

Log in

Vitamin E Transporters in Cancer Therapy

  • Review Article
  • Theme: Transporters and Cancer Therapy
  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

Besides their potent antioxidant activity, vitamin E isoforms demonstrated multiple therapeutic activities among which is their activity against different cancer types, including breast, prostate, and colon cancers. However, the activity of vitamin E isoforms is limited by their low bioavailability following oral administration. In addition to the low solubility, vitamin E isoforms have been established as substrates for several intestinal and hepatic transport proteins. In this review, we present reported anticancer activity of vitamin E family members and the possible utilization of vitamin E and derivatives as chemosensitizers to reverse multidrug resistance when given as part of a delivery system and/or in combination with anticancer therapeutic drugs. Then, the review discusses disposition of vitamin E members and transport proteins that play a role in determining their systemic bioavailability followed by recent advances in vitamin E formulations and delivery strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. science. 1922;56(1458):650–1.

    Article  CAS  PubMed  Google Scholar 

  2. Niki E, Traber MG. A history of vitamin E. Ann Nutr Metab. 2012;61(3):207–12.

    Article  CAS  PubMed  Google Scholar 

  3. Jiang Q, Christen S, Shigenaga MK, Ames BN. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001;74(6):714–22.

    CAS  PubMed  Google Scholar 

  4. Wong RS, Radhakrishnan AK. Tocotrienol research: past into present. Nutr Rev. 2012;70(9):483–90.

    Article  PubMed  Google Scholar 

  5. Wada S. Cancer preventive effects of vitamin E. Curr Pharm Biotechnol. 2012;13(1):156–64.

    Article  CAS  PubMed  Google Scholar 

  6. Heinonen M, Piironen V. The tocopherol, tocotrienol, and vitamin E content of the average Finnish diet. Int J Vitam Nutr Res. 1991;61(1):27–32.

    CAS  PubMed  Google Scholar 

  7. Azzi A, Ricciarelli R, Zingg JM. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett. 2002;519(1–3):8–10.

    Article  CAS  PubMed  Google Scholar 

  8. Frank J. Beyond vitamin E supplementation: an alternative strategy to improve vitamin E status. J Plant Physiol. 2005;162(7):834–43.

    Article  CAS  PubMed  Google Scholar 

  9. Brigelius-Flohe R. Bioactivity of vitamin E. Nutr Res Rev. 2006;19(2):174–86.

    Article  CAS  PubMed  Google Scholar 

  10. Freinbichler W, Colivicchi MA, Stefanini C, Bianchi L, Ballini C, Misini B, et al. Highly reactive oxygen species: detection, formation, and possible functions. Cell Mol Life Sci. 2011;68(12):2067–79.

    Article  CAS  PubMed  Google Scholar 

  11. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47(5):469–84.

    Article  CAS  PubMed  Google Scholar 

  12. Muller L, Theile K, Bohm V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol Nutr Food Res. 2010;54(5):731–42.

    Article  PubMed  Google Scholar 

  13. Suzuki YJ, Tsuchiya M, Wassall SR, Choo YM, Govil G, Kagan VE, et al. Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency. Biochemistry. 1993;32(40):10692–9.

    Article  CAS  PubMed  Google Scholar 

  14. Mustacich DJ, Bruno RS, Traber MG. Vitamin E. Vitam Horm. 2007;76:1–21.

    Article  CAS  PubMed  Google Scholar 

  15. Palozza P, Verdecchia S, Avanzi L, Vertuani S, Serini S, Iannone A, et al. Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells. Mol Cell Biochem. 2006;287(1–2):21–32.

    Article  CAS  PubMed  Google Scholar 

  16. Sylvester PW, Kaddoumi A, Nazzal S, El Sayed KA. The value of tocotrienols in the prevention and treatment of cancer. J Am Coll Nutr. 2010;29(3 Suppl):324S–33.

    Article  CAS  PubMed  Google Scholar 

  17. Constantinou C, Papas A, Constantinou AI. Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer. 2008;123(4):739–52.

    Article  CAS  PubMed  Google Scholar 

  18. Kline K, Lawson KA, Yu W, Sanders BG. Vitamin E and cancer. Vitam Horm. 2007;76:435–61.

    Article  CAS  PubMed  Google Scholar 

  19. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A. 1997;94(7):3217–22.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. El Golli E, Hassen W, Bouslimi A, Bouaziz C, Ladjimi MM, Bacha H. Induction of Hsp 70 in Vero cells in response to mycotoxins cytoprotection by sub-lethal heat shock and by vitamin E. Toxicol Lett. 2006;166(2):122–30.

    Article  PubMed  Google Scholar 

  21. Kannappan R, Ravindran J, Prasad S, Sung B, Yadav VR, Reuter S, et al. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors. Mol Cancer Ther. 2010;9(8):2196–207.

    Article  CAS  PubMed  Google Scholar 

  22. Gunawardena K, Murray DK, Meikle AW. Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate. 2000;44(4):287–95.

    Article  CAS  PubMed  Google Scholar 

  23. Shklar G, Schwartz JL. Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis. Eur J Cancer B Oral Oncol. 1996;32B(2):114–9.

    Article  CAS  PubMed  Google Scholar 

  24. Gysin R, Azzi A, Visarius T. Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J. 2002;16(14):1952–4.

    CAS  PubMed  Google Scholar 

  25. Takahashi S, Takeshita K, Seeni A, Sugiura S, Tang M, Sato SY, et al. Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling. Prostate. 2009;69(6):644–51.

    Article  CAS  PubMed  Google Scholar 

  26. Yu W, Sanders BG, Kline K. RRR-alpha-tocopheryl succinate induction of DNA synthesis arrest of human MDA-MB-435 cells involves TGF-beta-independent activation of p21Waf1/Cip1. Nutr Cancer. 2002;43(2):227–36.

    Article  CAS  PubMed  Google Scholar 

  27. Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, et al. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate. 2007;67(6):582–90.

    Article  CAS  PubMed  Google Scholar 

  28. Barnett KT, Fokum FD, Malafa MP. Vitamin E succinate inhibits colon cancer liver metastases. J Surg Res. 2002;106(2):292–8.

    Article  CAS  PubMed  Google Scholar 

  29. Duhem N, Danhier F, Preat V. Vitamin E-based nanomedicines for anti-cancer drug delivery. J Control Release. 2014;182:33–44.

    Article  CAS  PubMed  Google Scholar 

  30. Lawson KA, Anderson K, Menchaca M, Atkinson J, Sun L, Knight V, et al. Novel vitamin E analogue decreases syngeneic mouse mammary tumor burden and reduces lung metastasis. Mol Cancer Ther. 2003;2(5):437–44.

    CAS  PubMed  Google Scholar 

  31. Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med. 2007;28(5–6):692–728.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Wada S, Satomi Y, Murakoshi M, Noguchi N, Yoshikawa T, Nishino H. Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett. 2005;229(2):181–91.

    Article  CAS  PubMed  Google Scholar 

  33. Srivastava JK, Gupta S. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun. 2006;346(2):447–53.

    Article  CAS  PubMed  Google Scholar 

  34. Sun W, Xu W, Liu H, Liu J, Wang Q, Zhou J, et al. Gamma-tocotrienol induces mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem. 2009;20(4):276–84.

    Article  CAS  PubMed  Google Scholar 

  35. Samant GV, Wali VB, Sylvester PW. Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression. Cell Prolif. 2010;43(1):77–83.

    Article  CAS  PubMed  Google Scholar 

  36. Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, Lee TK, et al. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Int J Cancer. 2011;128(9):2182–91.

    Article  CAS  PubMed  Google Scholar 

  37. Ayoub NM, Bachawal SV, Sylvester PW. Gamma-tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells. Cell Prolif. 2011;44(6):516–26.

    Article  CAS  PubMed  Google Scholar 

  38. Ayoub NM, Akl MR, Sylvester PW. Combined gamma-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration. Cell Prolif. 2013;46(5):538–53.

    CAS  PubMed  Google Scholar 

  39. Komiyama K, Iizuka K, Yamaoka M, Watanabe H, Tsuchiya N, Umezawa I. Studies on the biological activity of tocotrienols. Chem Pharm Bull (Tokyo). 1989;37(5):1369–71.

    Article  CAS  Google Scholar 

  40. Selvaduray KR, Radhakrishnan AK, Kutty MK, Nesaretnam K. Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA. J Interferon Cytokine Res. 2010;30(12):909–16.

    Article  CAS  PubMed  Google Scholar 

  41. Liu HK, Wang Q, Li Y, Sun WG, Liu JR, Yang YM, et al. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem. 2010;21(3):206–13.

    Article  CAS  PubMed  Google Scholar 

  42. Abdul Hafid SR, Chakravarthi S, Nesaretnam K, Radhakrishnan AK. Tocotrienol-adjuvanted dendritic cells inhibit tumor growth and metastasis: a murine model of breast cancer. PLoS One. 2013;8(9):e74753.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Cardenas E, Ghosh R. Vitamin E: a dark horse at the crossroad of cancer management. Biochem Pharmacol. 2013;86(7):845–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90(6):440–6.

    Article  CAS  PubMed  Google Scholar 

  45. Alkhenizan A, Hafez K. The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Ann Saudi Med. 2007;27(6):409–14.

    Article  PubMed  Google Scholar 

  46. Brinkman MT, Karagas MR, Zens MS, Schned A, Reulen RC, Zeegers MP. Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control. 2010;21(4):609–19.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Nesaretnam K, Gomez PA, Selvaduray KR, Razak GA. Tocotrienol levels in adipose tissue of benign and malignant breast lumps in patients in Malaysia. Asia Pac J Clin Nutr. 2007;16(3):498–504.

    CAS  PubMed  Google Scholar 

  48. Yoshida Y, Niki E, Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids. 2003;123(1):63–75.

    Article  CAS  PubMed  Google Scholar 

  49. Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996;144(2):165–74.

    Article  CAS  PubMed  Google Scholar 

  50. Palan PR, Goldberg GL, Basu J, Runowicz CD, Romney SL. Lipid-soluble antioxidants: beta-carotene and alpha-tocopherol levels in breast and gynecologic cancers. Gynecol Oncol. 1994;55(1):72–7.

    Article  CAS  PubMed  Google Scholar 

  51. Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549–56.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2(1):48–58.

    Article  CAS  PubMed  Google Scholar 

  53. Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 2002;16(4–5):237–46.

    Article  CAS  PubMed  Google Scholar 

  54. Li PY, Lai PS, Hung WC, Syu WJ. Poly(l-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells. Biomacromolecules. 2010;11(10):2576–82.

    Article  CAS  PubMed  Google Scholar 

  55. Liu Y, Huang L, Liu F. Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. Mol Pharm. 2010;7(3):863–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, et al. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro. Nanotechnology. 2012;23(49):495103.

    Article  PubMed  Google Scholar 

  57. Kutty RV, Feng SS. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. Biomaterials. 2013;34(38):10160–71.

    Article  CAS  PubMed  Google Scholar 

  58. Wang Z, Zeng X, Ma Y, Liu J, Tang X, Gao Y, et al. Antitumor efficiency of d-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer. J Biomed Nanotechnol. 2014;10(8):1509–19.

    Article  PubMed  Google Scholar 

  59. Tang J, Fu Q, Wang Y, Racette K, Wang D, Liu F. Vitamin E reverses multidrug resistance in vitro and in vivo. Cancer Lett. 2013;336(1):149–57.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Behrens WA, Madere R. Mechanisms of absorption, transport and tissue uptake of RRR-alpha-tocopherol and d-gamma-tocopherol in the white rat. J Nutr. 1987;117(9):1562–9.

    CAS  PubMed  Google Scholar 

  61. Clement M, Bourre JM. Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle of vitamin-E-deficient rats. Biochim Biophys Acta. 1997;1334(2–3):173–81.

    Article  CAS  PubMed  Google Scholar 

  62. Behrens WA, Madere R. Alpha- and gamma tocopherol concentrations in human serum. J Am Coll Nutr. 1986;5(1):91–6.

    Article  CAS  PubMed  Google Scholar 

  63. Hayes KC, Pronczuk A, Liang JS. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters. Proc Soc Exp Biol Med. 1993;202(3):353–9.

    Article  CAS  PubMed  Google Scholar 

  64. Abuasal BS, Qosa H, Sylvester PW, Kaddoumi A. Comparison of the intestinal absorption and bioavailability of gamma-tocotrienol and alpha-tocopherol: in vitro, in situ and in vivo studies. Biopharm Drug Dispos. 2012;33(5):246–56.

    Article  CAS  PubMed  Google Scholar 

  65. Yap SP, Yuen KH, Lim AB. Influence of route of administration on the absorption and disposition of alpha-, gamma- and delta-tocotrienols in rats. J Pharm Pharmacol. 2003;55(1):53–8.

    Article  CAS  PubMed  Google Scholar 

  66. Abuasal B, Sylvester PW, Kaddoumi A. Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies. Drug Metab Dispos. 2010;38(6):939–45.

    Article  CAS  PubMed  Google Scholar 

  67. Alqahtani S, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A. Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies. AAPS J. 2013;15(3):684–95.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  68. Yap SP, Yuen KH, Wong JW. Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status. J Pharm Pharmacol. 2001;53(1):67–71.

    Article  CAS  PubMed  Google Scholar 

  69. Kayden HJ, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res. 1993;34(3):343–58.

    CAS  PubMed  Google Scholar 

  70. Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, Schneider M, et al. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. J Biol Chem. 2006;281(8):4739–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Wang J, Chu BB, Ge L, Li BL, Yan Y, Song BL. Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption. J Lipid Res. 2009;50(8):1653–62.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. Narushima K, Takada T, Yamanashi Y, Suzuki H. Niemann-Pick C1-like 1 mediates alpha-tocopherol transport. Mol Pharmacol. 2008;74(1):42–9.

    Article  CAS  PubMed  Google Scholar 

  73. Reboul E, Soayfane Z, Goncalves A, Cantiello M, Bott R, Nauze M, et al. Respective contributions of intestinal Niemann-Pick C1-like 1 and scavenger receptor class B type I to cholesterol and tocopherol uptake: in vivo v. in vitro studies. Br J Nutr. 2012;107(9):1296–304.

    Article  CAS  PubMed  Google Scholar 

  74. Hussain MM, Fatma S, Pan X, Iqbal J. Intestinal lipoprotein assembly. Curr Opin Lipidol. 2005;16(3):281–5.

    Article  CAS  PubMed  Google Scholar 

  75. Reboul E, Trompier D, Moussa M, Klein A, Landrier JF, Chimini G, et al. ATP-binding cassette transporter A1 is significantly involved in the intestinal absorption of alpha- and gamma-tocopherol but not in that of retinyl palmitate in mice. Am J Clin Nutr. 2009;89(1):177–84.

    Article  CAS  PubMed  Google Scholar 

  76. Kaempf-Rotzoll DE, Traber MG, Arai H. Vitamin E and transfer proteins. Curr Opin Lipidol. 2003;14(3):249–54.

    Article  CAS  PubMed  Google Scholar 

  77. Podda M, Weber C, Traber MG, Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. J Lipid Res. 1996;37(4):893–901.

    CAS  PubMed  Google Scholar 

  78. Traber MG, Rallis M, Podda M, Weber C, Maibach HI, Packer L. Penetration and distribution of alpha-tocopherol, alpha- or gamma-tocotrienols applied individually onto murine skin. Lipids. 1998;33(1):87–91.

    Article  CAS  PubMed  Google Scholar 

  79. Shichiri M, Takanezawa Y, Rotzoll DE, Yoshida Y, Kokubu T, Ueda K, et al. ATP-binding cassette transporter A1 is involved in hepatic alpha-tocopherol secretion. J Nutr Biochem. 2010;21(5):451–6.

    Article  CAS  PubMed  Google Scholar 

  80. Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem. 2002;277(28):25290–6.

    Article  CAS  PubMed  Google Scholar 

  81. Mustacich DJ, Shields J, Horton RA, Brown MK, Reed DJ. Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. Arch Biochem Biophys. 1998;350(2):183–92.

    Article  CAS  PubMed  Google Scholar 

  82. Upadhyay J, Misra K. Towards the interaction mechanism of tocopherols and tocotrienols (vitamin E) with selected metabolizing enzymes. Bioinformation. 2009;3(8):326–31.

    Article  PubMed Central  PubMed  Google Scholar 

  83. Park SW. Intestinal and hepatic Niemann-Pick C1-like 1. Diabetes Metab J. 2013;37(4):240–8.

    Article  PubMed Central  PubMed  Google Scholar 

  84. Dressman JB, Amidon GL, Fleisher D. Absorption potential: estimating the fraction absorbed for orally administered compounds. J Pharm Sci. 1985;74(5):588–9.

    Article  CAS  PubMed  Google Scholar 

  85. Abuasal BS, Lucas C, Peyton B, Alayoubi A, Nazzal S, Sylvester PW, et al. Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases gamma-tocotrienol oral bioavailability. Lipids. 2012;47(5):461–9.

    Article  CAS  PubMed  Google Scholar 

  86. Alqahtani S, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A. Enhanced solubility and oral bioavailability of gamma-tocotrienol using a self-emulsifying drug delivery system (SEDDS). Lipids. 2014.

  87. Yap SP, Yuen KH. Influence of lipolysis and droplet size on tocotrienol absorption from self-emulsifying formulations. Int J Pharm. 2004;281(1–2):67–78.

    Article  CAS  PubMed  Google Scholar 

  88. Miyoshi N, Wakao Y, Tomono S, Tatemichi M, Yano T, Ohshima H. The enhancement of the oral bioavailability of gamma-tocotrienol in mice by gamma-cyclodextrin inclusion. J Nutr Biochem. 2011;22(12):1121–6.

    Article  CAS  PubMed  Google Scholar 

  89. Emami J, Rezazadeh M, Rostami M, Hassanzadeh F, Sadeghi H, Mostafavi A, et al. Co-delivery of paclitaxel and alpha-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Drug Dev Ind Pharm. 2014:1–11.

  90. Serbinova E, Kagan V, Han D, Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic Biol Med. 1991;10(5):263–75.

    Article  CAS  PubMed  Google Scholar 

  91. Tahan G, Aytac E, Aytekin H, Gunduz F, Dogusoy G, Aydin S, et al. Vitamin E has a dual effect of anti-inflammatory and antioxidant activities in acetic acid-induced ulcerative colitis in rats. Can J Surg. 2011;54(5):333–8.

    Article  PubMed Central  PubMed  Google Scholar 

  92. Wu SJ, Liu PL, Ng LT. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res. 2008;52(8):921–9.

    Article  CAS  PubMed  Google Scholar 

  93. Aggarwal B, Nesaretnam K. Vitamin E tocotrienols: life beyond tocopherols. Genes Nutr. 2012;7(1):1.

    Article  PubMed Central  PubMed  Google Scholar 

  94. Sen CK, Khanna S, Roy S. Tocotrienols: vitamin E beyond tocopherols. Life Sci. 2006;78(18):2088–98.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  95. Rink C, Christoforidis G, Khanna S, Peterson L, Patel Y, Khanna S, et al. Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis. J Cereb Blood Flow Metab. 2011;31(11):2218–30.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  96. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1993;268(15):11230–8.

    CAS  PubMed  Google Scholar 

  97. Zaiden N, Yap WN, Ong S, Xu CH, Teo VH, Chang CP, et al. Gamma delta tocotrienols reduce hepatic triglyceride synthesis and VLDL secretion. J Atheroscler Thromb. 2010;17(10):1019–32.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amal Kaddoumi.

Additional information

Guest Editor: Rajgopal Govindarajan

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alqahtani, S., Kaddoumi, A. Vitamin E Transporters in Cancer Therapy. AAPS J 17, 313–322 (2015). https://doi.org/10.1208/s12248-014-9705-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-014-9705-5

KEY WORDS

Navigation